Dietary Treatment Study of Fat Synthesis and Risk of Cardiovascular Disease
Lipogenesis, Lipoprotein Flux, and CVD Risk: Role of Meal Composition and Frequency
1 other identifier
interventional
48
1 country
1
Brief Summary
The purpose of this study is to find out how the amount of fat or sugar in a person's diet, or the number of meals eaten each day, affect the amount of fat that people's bodies make, the types of fats in the bloodstream, and how much fat is stored in the liver. The study is funded by the National Institutes of Health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 26, 2014
CompletedFirst Posted
Study publicly available on registry
March 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMay 19, 2022
May 1, 2022
9.4 years
February 26, 2014
May 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of meal composition on fractional de novo lipogenesis (fatty acid synthesis)
Differences between high carbohydrate and high fat diets on postprandial de novo lipogenesis De novo lipogenesis will be measured using stable (not radioactive) isotopes given intravenously and orally during feeding.
After 10-day dietary period
Secondary Outcomes (1)
Effect of meal frequency on fractional de novo lipogenesis (fatty acid synthesis)
After 10-day dietary period
Other Outcomes (2)
Liver fat content
After 10-day dietary period
Lipids and lipoproteins in the blood
After 10-day dietary intervention period
Study Arms (6)
High sugar/meal feed
EXPERIMENTALDiet high in simple sugar fed as two large meals daily
High sugar/nibble
EXPERIMENTALDiet high in simple sugar fed as 8 small meals daily
High fat/meal feed
EXPERIMENTALDiet high in fat fed as two large meals daily
High fat/nibble
EXPERIMENTALDiet high in fat fed as 8 small meals daily
High sugar/3 meals a day
EXPERIMENTALDiet high in simple sugar fed as 3 meals a day
High fat/ 3 meals a day
EXPERIMENTALDiet high in fat fed as 3 meals a day
Interventions
Weight-maintaining diet relatively high in sugar fed as two large meals daily
Weight-maintaining diet relatively high in sugar fed as 8 meals daily
Weight-maintaining diet relatively high in fat fed as two large meals daily
Weight-maintaining diet relatively high in fat fed as 8 small meals daily
Weight-maintaining diet relatively high in sugar fed as 3 meals daily
Weight-maintaining diet relatively high in fat fed as 3 meals daily
Eligibility Criteria
You may qualify if:
- overweight or obese men and women
- ages 20-65 years
You may not qualify if:
- pregnancy or lactation within the past six months
- type 1 or 2 diabetes mellitus\]
- AST and ALT above upper limit of normal (ULN)
- fasting triglyceride or total cholesterol levels \>ULN
- Hgb below the lower of limit of normal
- positive HIV antibody test or hepatitis serologies
- use of any antidiabetic medications or lipid-lowering drugs
- history of surgery for obesity
- change in body weight \>5% within preceding 6 months (self report)
- claustrophobia, presence of metal implants
- weight over 350 lbs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Franciso, San Francisco General Hospital
San Francisco, California, 94110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen Mulligan, PhD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Jean-Marc Schwarz, PhD
Touro University, California
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2014
First Posted
March 3, 2014
Study Start
July 1, 2013
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
May 19, 2022
Record last verified: 2022-05